Literature DB >> 16798313

Inhaled nitric oxide reduces ischemia-reperfusion injury in rat lungs from non-heart-beating donors.

Seiki Takashima1, Giovanna Koukoulis, Hidetoshi Inokawa, Mayura Sevala, Thomas M Egan.   

Abstract

OBJECTIVE: If lungs could be retrieved from non-heart-beating donors, the critical shortage of lungs for transplantation could be alleviated. However, lungs subjected to warm ischemia develop edema when reperfused. We hypothesized that ventilation of rat lungs from non-heart-beating donors with nitric oxide during the period of warm ischemia alone, with reperfusion, or both might reduce ischemia-reperfusion injury.
METHODS: An isolated perfused rat lung model measured the filtration coefficient and accumulation of lung water by the wet/dry weight ratio. Donor rats were euthanized, and then lungs were retrieved immediately after death or 2 or 3 hours postmortem. Lungs retrieved postmortem were either not ventilated or ventilated with 100% oxygen alone or 40 ppm nitric oxide in oxygen. In the circuit, lungs were ventilated with alveolar gas with or without 40 ppm nitric oxide.
RESULTS: Nitric oxide administration to the non-heart-beating donor or in the perfusion circuit reduced filtration coefficient and wet/dry weight ratio. Lungs retrieved 2 hours postmortem ventilated with nitric oxide or treated with nitric oxide on reperfusion had filtration coefficients and wet/dry weight ratios similar to those of lungs retrieved immediately after death. Nitric oxide was most beneficial when administered both during warm ischemia and at reperfusion in lungs retrieved 3 hours postmortem. Nitric oxide administration in the circuit was associated with increased lung levels of lung cyclic guanosine monophosphate, determined by enzyme-linked immunosorbent assay.
CONCLUSIONS: Administration of nitric oxide to non-heart-beating donors during warm ischemia and with reperfusion might facilitate transplantation of lungs from non-heart-beating donors by reducing ischemia-reperfusion injury and capillary leak.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798313     DOI: 10.1016/j.jtcvs.2006.02.032

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

Review 1.  Inhaled pulmonary vasodilators: a narrative review.

Authors:  Kai Liu; Huan Wang; Shen-Ji Yu; Guo-Wei Tu; Zhe Luo
Journal:  Ann Transl Med       Date:  2021-04

2.  Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema.

Authors:  Giorgio Zanotti; Monica Casiraghi; John B Abano; Jason R Tatreau; Mayura Sevala; Hilary Berlin; Susan Smyth; William K Funkhouser; Keith Burridge; Scott H Randell; Thomas M Egan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-04-17       Impact factor: 5.464

Review 3.  Lung transplantation from donation after cardiac death (non-heart-beating) donors.

Authors:  Takahiro Oto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-11-12

Review 4.  Minimizing Ischemia Reperfusion Injury in Xenotransplantation.

Authors:  Parth M Patel; Margaret R Connolly; Taylor M Coe; Anthony Calhoun; Franziska Pollok; James F Markmann; Lars Burdorf; Agnes Azimzadeh; Joren C Madsen; Richard N Pierson
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

5.  Nicorandil, a KATP Channel Opener, Attenuates Ischemia-Reperfusion Injury in Isolated Rat Lungs.

Authors:  Kyoko Abe; Takashi Horiguchi; Keiji Enzan; Yoko Masaki; Toshiaki Nishikawa; Tetsu Kimura
Journal:  Lung       Date:  2020-02-21       Impact factor: 2.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.